Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

February 21, 2025
Vol.51 No.07
In Brief

Jason Damsker and Michael Noonan join Fox Chase

February 21, 2025
Vol.51 No.07
Chadi Nabhan: Why I wrote a book about cancer
Trials & Tribulations

Chadi Nabhan: Why I wrote a book about cancer

January 17, 2025
Vol.51 No.02
By Chadi Nabhan
In Brief

Jennifer Woyach named director of OSUCCC—James’s Division of Hematology

January 17, 2025
Vol.51 No.02
In Brief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

December 06, 2024
Vol.50 No.45
Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

December 06, 2024
Vol.50 No.45
In Brief

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

October 25, 2024
Vol.50 No.40
In Brief

Michael Seidman joins Fox Chase Department of Hematology/Oncology

August 09, 2024
Vol.50 No.32
Infections are a major cause of death in patients treated with CAR T-cell therapy
Conversation with The Cancer Letter

Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence

July 12, 2024
Vol.50 No.28
By Matthew Bin Han Ong
In Brief

Tiffany Seagroves joins Tulane Cancer Center

July 12, 2024
Vol.50 No.28

Posts navigation

Previous123…6Next

Trending Stories

  • Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
    PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.”
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
  • NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
  • Most Favored Nation drug pricing could put China on top
  • Protecting the cure: Why the future of radiation oncology must be precision-guided

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account